These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1111162)

  • 21. Drug usage review in a community hospital.
    Kelly WN; White JA; Miller DE
    Am J Hosp Pharm; 1975 Oct; 32(10):1014-7. PubMed ID: 1190212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restricted formulary drugs: an exploratory study.
    Rucker TD
    Hosp Pharm; 1982 May; 17(5):246-53. PubMed ID: 10255245
    [No Abstract]   [Full Text] [Related]  

  • 23. [The pharmacological committee yesterday, today and tomorrow].
    Lepakhin VK
    Ter Arkh; 1990; 62(9):4-7. PubMed ID: 2281404
    [No Abstract]   [Full Text] [Related]  

  • 24. [Swedish drug information of international interest].
    Osterberg S
    Lakartidningen; 1975 Jun; 72(26):2743. PubMed ID: 1142909
    [No Abstract]   [Full Text] [Related]  

  • 25. [Proposal for agreement and budget for a Scandinavian pharmacy and therapeutics committee].
    Idänpään-Heikkilä J
    Nord Med; 1974 Jan; 89(1):12. PubMed ID: 4819424
    [No Abstract]   [Full Text] [Related]  

  • 26. Sales statistics in the control of drug abuse in Norway.
    Jøldal B; Halvorsen I
    Bull Narc; 1982; 34(2):57-68. PubMed ID: 6129015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacy: computerless drug use review.
    Deliganis SG; Johnson SR
    Hospitals; 1973 Dec; 47(23):86 passim. PubMed ID: 4761628
    [No Abstract]   [Full Text] [Related]  

  • 28. [Round table discussion on the Scandinavian drug market: A common pharmacy and therapeutics committee is proposed in view of threats from abroad of lowered standards].
    Nord Med; 1974 Jan; 89(1):3-5. PubMed ID: 4856475
    [No Abstract]   [Full Text] [Related]  

  • 29. The P&T committee and drug use review.
    Provost GP
    Hosp Formul; 1979 May; 14(5):596, 594. PubMed ID: 10242199
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug utilization reviews--a major responsibility of the P&T committee: an administrative overview.
    Godwin HN
    Hosp Formul; 1981 Jun; 16(6):609, 613-5. PubMed ID: 10251441
    [No Abstract]   [Full Text] [Related]  

  • 31. Filling and refilling practices with diazepam and methyldopa.
    Scrivens JJ; Weber C; Sather M; Geck W
    Hosp Formul; 1979 Sep; 14(9):830-1,834-6,838. PubMed ID: 10243909
    [No Abstract]   [Full Text] [Related]  

  • 32. Concurrent antibiotic use evaluation in a community hospital.
    Merryfield DW; Wooten JM; Gupta MR
    Hosp Formul; 1991 Oct; 26(10):820-2. PubMed ID: 10114500
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of criteria developed before formulary addition to evaluate misoprostol use.
    Rice KM; LeRoy ML; Ivey MF; Deck C; Krstenansky P
    Am J Hosp Pharm; 1992 Mar; 49(3):629-31. PubMed ID: 1598943
    [No Abstract]   [Full Text] [Related]  

  • 34. Predetermined standards in drug use control.
    Lipman AG
    Hosp Formul; 1979 Sep; 14(9):864. PubMed ID: 10243911
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduction of benzodiazepine use.
    Bourinskie JE
    Am J Hosp Pharm; 1978 Sep; 35(9):1035, 1038. PubMed ID: 29484
    [No Abstract]   [Full Text] [Related]  

  • 36. An approach to regulating cephalosporin use and costs.
    Ryan JL; Francese J
    Hosp Formul; 1980 Sep; 15(9):674-6. PubMed ID: 10248357
    [No Abstract]   [Full Text] [Related]  

  • 37. [Are the recommendations of the drug committee followed? A comparison of the prescribing pattern of anti-angina drugs in general practice and hospitals in relation to the recommendations].
    Salomonsen H; Beierholm V
    Ugeskr Laeger; 1991 Aug; 153(34):2333-5. PubMed ID: 1897041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug committees, choice of drugs and drug information].
    Lundh B
    Lakartidningen; 1988 Nov; 85(44):3641-3. PubMed ID: 3199994
    [No Abstract]   [Full Text] [Related]  

  • 39. [Definition of the drug given in 1969 by a committee of WHO experts].
    Quevauviller A; Mabileau J; Vaille C
    Ann Pharm Fr; 1969 Jun; 27(6):403-9. PubMed ID: 5392371
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug committees should be abolished because the reality has changed].
    Jönsson B; Arvidsson G; Levin LA; Rehnberg C
    Lakartidningen; 2005 Mar 14-20; 102(11):880-1; discussion 882-3. PubMed ID: 15835525
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.